Skip to main content
Premium Trial:

Request an Annual Quote

New England Biolabs, Directed Genomics Partner on NGS-based Target Enrichment Technology

NEW YORK (GenomeWeb) – New England Biolabs and Directed Genomics today announced a partnership to develop new next-generation sequencing-based target enrichment technologies.

The first product to be developed will be a target enrichment technology combining enrichment with NGS library construction into a single, seamless protocol. The partners said the approach is scalable and will enable researchers to convert small amounts of genomic DNA into sequence-ready libraries in about six hours. They added that enrichment is highly specific and enables greater coverage of target regions with fewer sequencing reads than currently available target-capture methods.

Financial and other terms of the deal were not disclosed.

"Partnering with NEB allows us to leverage an extensive knowledgebase of enzyme activities, best-in-class manufacturing practices, and their global commercial footprint," Directed Genomics Founder and President Cynthia Richard said in a statement.

The Scan

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.

Using Bees to Gain Insights into Urban Microbiomes

As bees buzz around, they pick up debris that provides insight into the metagenome of their surroundings, researchers report in Environmental Microbiome.

Age, Genetic Risk Tied to Blood Lipid Changes in New Study

A study appearing in JAMA Network Open suggests strategies to address high lipid levels should focus on individuals with high genetic risk and at specific ages.

Study Examines Insights Gained by Adjunct Trio RNA Sequencing in Complex Pediatric Disease Cases

Researchers in AJHG explore the diagnostic utility of adding parent-child RNA-seq to genome sequencing in dozens of families with complex, undiagnosed genetic disease.